Down 14 cents today on low volume, yet leading into the Oppenheimer presentation on 11/10 and Genentech presentation on 11/19.

The market makers won't be satisfied until they get it under the $2 threshold to trigger margin calls (I had one in the last week, but E Trade rescinded after the stock went back above $2).